Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants

Susanna Esposito, Giacomo Faldella, Anna Giammanco, Samantha Bosis, Ornella Friscia, Mario Clerici, Nicola Principi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Immunoglobulin G (IgG) antibody titres against pertussis antigens, Bordetella pertussis-specific proliferation and cytokine production by peripheral blood mononuclear cells (PBMCs) were evaluated at the age of 5-6 years in 13 children who had been pre-term infants with a gestational age (GA) of ≤31 weeks, 10 who had been pre-term infants with a GA of 32-37 weeks, and 15 who had been term infants with a GA of 38-42 weeks. All of the infants had been immunised with a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine (DTaP-HBV) at 3, 5, and 11 months of post-natal age. Our results show that the long-term immune responses induced by primary pertussis vaccination in the pre-term infants (especially those with a GA of ≤31 weeks) were qualitatively and quantitatively lower than those observed in the term infants. In order to maintain an adequate pertussis-specific immune response, in term children a booster at 5-6 years of age may be suggested, whereas in pre-term an earlier booster should be useful.

Original languageEnglish
Pages (from-to)2928-2932
Number of pages5
JournalVaccine
Volume20
Issue number23-24
DOIs
Publication statusPublished - Jul 26 2002

Fingerprint

whooping cough
Hepatitis B Vaccines
Diphtheria
Whooping Cough
gestational age
tetanus
hepatitis B
Tetanus
immune response
vaccines
Gestational Age
Bordetella pertussis
immunoglobulin G
mononuclear leukocytes
cytokines
vaccination
antigens
antibodies
Blood Cells
Vaccination

Keywords

  • DTaP-HBV vaccine
  • Pertussis
  • Pre-term infants

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants. / Esposito, Susanna; Faldella, Giacomo; Giammanco, Anna; Bosis, Samantha; Friscia, Ornella; Clerici, Mario; Principi, Nicola.

In: Vaccine, Vol. 20, No. 23-24, 26.07.2002, p. 2928-2932.

Research output: Contribution to journalArticle

Esposito, Susanna ; Faldella, Giacomo ; Giammanco, Anna ; Bosis, Samantha ; Friscia, Ornella ; Clerici, Mario ; Principi, Nicola. / Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants. In: Vaccine. 2002 ; Vol. 20, No. 23-24. pp. 2928-2932.
@article{2b14e7e66a24401ca0c4e748afdaf46a,
title = "Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants",
abstract = "Immunoglobulin G (IgG) antibody titres against pertussis antigens, Bordetella pertussis-specific proliferation and cytokine production by peripheral blood mononuclear cells (PBMCs) were evaluated at the age of 5-6 years in 13 children who had been pre-term infants with a gestational age (GA) of ≤31 weeks, 10 who had been pre-term infants with a GA of 32-37 weeks, and 15 who had been term infants with a GA of 38-42 weeks. All of the infants had been immunised with a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine (DTaP-HBV) at 3, 5, and 11 months of post-natal age. Our results show that the long-term immune responses induced by primary pertussis vaccination in the pre-term infants (especially those with a GA of ≤31 weeks) were qualitatively and quantitatively lower than those observed in the term infants. In order to maintain an adequate pertussis-specific immune response, in term children a booster at 5-6 years of age may be suggested, whereas in pre-term an earlier booster should be useful.",
keywords = "DTaP-HBV vaccine, Pertussis, Pre-term infants",
author = "Susanna Esposito and Giacomo Faldella and Anna Giammanco and Samantha Bosis and Ornella Friscia and Mario Clerici and Nicola Principi",
year = "2002",
month = "7",
day = "26",
doi = "10.1016/S0264-410X(02)00230-X",
language = "English",
volume = "20",
pages = "2928--2932",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "23-24",

}

TY - JOUR

T1 - Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants

AU - Esposito, Susanna

AU - Faldella, Giacomo

AU - Giammanco, Anna

AU - Bosis, Samantha

AU - Friscia, Ornella

AU - Clerici, Mario

AU - Principi, Nicola

PY - 2002/7/26

Y1 - 2002/7/26

N2 - Immunoglobulin G (IgG) antibody titres against pertussis antigens, Bordetella pertussis-specific proliferation and cytokine production by peripheral blood mononuclear cells (PBMCs) were evaluated at the age of 5-6 years in 13 children who had been pre-term infants with a gestational age (GA) of ≤31 weeks, 10 who had been pre-term infants with a GA of 32-37 weeks, and 15 who had been term infants with a GA of 38-42 weeks. All of the infants had been immunised with a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine (DTaP-HBV) at 3, 5, and 11 months of post-natal age. Our results show that the long-term immune responses induced by primary pertussis vaccination in the pre-term infants (especially those with a GA of ≤31 weeks) were qualitatively and quantitatively lower than those observed in the term infants. In order to maintain an adequate pertussis-specific immune response, in term children a booster at 5-6 years of age may be suggested, whereas in pre-term an earlier booster should be useful.

AB - Immunoglobulin G (IgG) antibody titres against pertussis antigens, Bordetella pertussis-specific proliferation and cytokine production by peripheral blood mononuclear cells (PBMCs) were evaluated at the age of 5-6 years in 13 children who had been pre-term infants with a gestational age (GA) of ≤31 weeks, 10 who had been pre-term infants with a GA of 32-37 weeks, and 15 who had been term infants with a GA of 38-42 weeks. All of the infants had been immunised with a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine (DTaP-HBV) at 3, 5, and 11 months of post-natal age. Our results show that the long-term immune responses induced by primary pertussis vaccination in the pre-term infants (especially those with a GA of ≤31 weeks) were qualitatively and quantitatively lower than those observed in the term infants. In order to maintain an adequate pertussis-specific immune response, in term children a booster at 5-6 years of age may be suggested, whereas in pre-term an earlier booster should be useful.

KW - DTaP-HBV vaccine

KW - Pertussis

KW - Pre-term infants

UR - http://www.scopus.com/inward/record.url?scp=0037178305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037178305&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(02)00230-X

DO - 10.1016/S0264-410X(02)00230-X

M3 - Article

C2 - 12126904

AN - SCOPUS:0037178305

VL - 20

SP - 2928

EP - 2932

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 23-24

ER -